# Sonia S. Anand

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sonia-s-anand/

## Facts

| Field | Value |
| --- | --- |
| Citations | 54,322 |
| Field | Peripheral Artery Disease Management |
| h-index | 102 |
| i10-index | 352 |
| Last Known Institution | Population Health Research Institute |
| OpenAlex ID | https://openalex.org/A5058205892 |
| ORCID iD | https://orcid.org/0000-0003-3692-7441 |
| Works | 660 |

## Researcher papers

Showing 12 of 17.

- [Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-stable-cardiovascular-disease/)
- [Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies](https://scholariq.org/papers/intake-of-saturated-and-trans-unsaturated-fatty-acids-and-risk-of-all-cause/)
- [Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes](https://scholariq.org/papers/adverse-impact-of-bleeding-on-prognosis-in-patients-with-acute-coronary/)
- [Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study](https://scholariq.org/papers/associations-of-fats-and-carbohydrate-intake-with-cardiovascular-disease-and/)
- [Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries](https://scholariq.org/papers/cardiovascular-risk-and-events-in-17-low-middle-and-high-income-countries/)
- [Rivaroxaban in Peripheral Artery Disease after Revascularization](https://scholariq.org/papers/rivaroxaban-in-peripheral-artery-disease-after-revascularization/)
- [Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation](https://scholariq.org/papers/multi-ancestry-genetic-study-of-type-2-diabetes-highlights-the-power-of-diverse/)
- [Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-patients-with-stable-coronary-artery/)
- [Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study](https://scholariq.org/papers/fruit-vegetable-and-legume-intake-and-cardiovascular-disease-and-deaths-in-18/)
- [Food Consumption and its Impact on Cardiovascular Disease: Importance of Solutions Focused on the Globalized Food System](https://scholariq.org/papers/food-consumption-and-its-impact-on-cardiovascular-disease-importance-of/)
- [Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin](https://scholariq.org/papers/safety-of-proton-pump-inhibitors-based-on-a-large-multi-year-randomized-trial-of/)
- [Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia](https://scholariq.org/papers/excess-of-rare-variants-in-genes-identified-by-genome-wide-association-study-of/)

## Researcher topics

- [Peripheral Artery Disease Management](https://scholariq.org/topics/peripheral-artery-disease-management/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Genetic Associations and Epidemiology](https://scholariq.org/topics/genetic-associations-and-epidemiology/)
- [Nutritional Studies and Diet](https://scholariq.org/topics/nutritional-studies-and-diet/)

## Researcher university

- [Population Health Research Institute](https://scholariq.org/institutions/population-health-research-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
